Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Novartis makes $500m investment in Russia

December 21, 2010 Manufacturing and Production, Research and Development Novartis, Russia, pharma manufacturing

Novartis is planning to invest $500 million in Russia over the next five years, in a programme which will include …
News

Biogen Idec buys neurodegenerative disease rights

December 21, 2010 Research and Development Alzheimer's, Alzheimer's disease, Alzheimer’s, Alzheimer’s disease, Biogen, Biogen IDEC, Neurimmune, Parkinson's disease, Parkinson’s disease, amyotrophic lateral sclerosis, neurodegenerative diseases

Biogen Idec has acquired a subsidiary of Swiss biotech company Neurimmune, and the rights to three pre-clinical immunotherapy drugs. The …
News

Contract research news in brief

December 20, 2010 Research and Development Biomodels, CIT, Charles River Laboratories, Dedicated Phase I, INC Research, PPD

Our round-up of recent development in the contract research sector includes updates from Charles River, CIT/Biomodels, INC Research, PPD and …
News
AstraZeneca’s antiplatelet tablet Brilinta (ticagrelor)

FDA delays approval of AstraZeneca’s Brilinta

December 20, 2010 Research and Development, Sales and Marketing AZ, AstraZeneca, Brilinta, Brilique, acute coronary syndrome

US regulators have delayed approving AstraZeneca’s antiplatelet tablet Brilinta (ticagrelor) because their want more information about a crucial clinical trial. …
News

Sanofi signs new oncology research deals

December 20, 2010 Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs

Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …
News

Sanofi and Merck Serono to collaborate in oncology

December 17, 2010 Research and Development Cancer, MSC1936369B, Merck Serono, SAR245408, SAR245409, Sanofi, Sanofi-Aventis

Sanofi-Aventis and Merck Serono are to join forces to study three new cancer drug candidates. The collaboration will see the companies …
News

Pharma careers options – management in China

December 17, 2010 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, careers, management, recruitment

Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …
Feature

New hepatitis C drug offers cure for more patients

December 17, 2010 Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir

A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …
News

Merck KGaA appoints new head of pharma

December 17, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing

Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …
Appointment

Novartis becomes global eye health leader as Alcon deal finalised

December 15, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology

Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
News

Patient deaths halt Lilly cancer trial

December 15, 2010 Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam

Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …
News

Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D

December 15, 2010 Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development

Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
Appointment

Sanofi extends Genzyme share deal deadline

December 14, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions

Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
News
Amgen HQ

Amgen and Actelion meet to “talk takeover”

December 13, 2010 Research and Development, Sales and Marketing Acelion, Amgen, pharma acquisitions, takeover

Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …
News

Novartis pulls Zometa submission after breast cancer failure

December 13, 2010 Research and Development, Sales and Marketing Novatis, Zometa, breast cancer, zoledronic

Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026